Biomarkers demonstrate characteristics of normal biological and pathogenic processes or to pharmacological responses to a therapeutic application. Validated biomarkers have utility throughout the drug discovery process and can help to shorten the life cycle from discovery to market.

IBA’s biomarker discovery group is well versed in the discipline of novel biomarker discovery. Through careful evaluation of biological data, we are able to identify molecular targets that have utility in your disease and therapeutic response.

For further information about IBA’s biomarker discovery please contact us (800) 315-4000.